128 related articles for article (PubMed ID: 22902653)
1. Modulation of cofilin phosphorylation by inhibition of the Lim family kinases.
He L; Seitz SP; Trainor GL; Tortolani D; Vaccaro W; Poss M; Tarby CM; Tokarski JS; Penhallow B; Hung CY; Attar R; Lin TA
Bioorg Med Chem Lett; 2012 Sep; 22(18):5995-8. PubMed ID: 22902653
[TBL] [Abstract][Full Text] [Related]
2. A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1.
Prudent R; Demoncheaux N; Diemer H; Collin-Faure V; Kapur R; Paublant F; Lafanechère L; Cianférani S; Rabilloud T
PLoS One; 2018; 13(12):e0208979. PubMed ID: 30550596
[TBL] [Abstract][Full Text] [Related]
3. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.
Arber S; Barbayannis FA; Hanser H; Schneider C; Stanyon CA; Bernard O; Caroni P
Nature; 1998 Jun; 393(6687):805-9. PubMed ID: 9655397
[TBL] [Abstract][Full Text] [Related]
4. Discovery, Development, and SAR of Aminothiazoles as LIMK Inhibitors with Cellular Anti-Invasive Properties.
Charles MD; Brookfield JL; Ekwuru TC; Stockley M; Dunn J; Riddick M; Hammonds T; Trivier E; Greenland G; Wong AC; Cheasty A; Boyd S; Crighton D; Olson MF
J Med Chem; 2015 Oct; 58(20):8309-13. PubMed ID: 26356364
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
Yu Q; Gratzke C; Wang Y; Herlemann A; Sterr CM; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Stief CG; Hennenberg M
Br J Pharmacol; 2018 Jun; 175(11):2077-2096. PubMed ID: 29574791
[TBL] [Abstract][Full Text] [Related]
6. Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors.
Yin Y; Zheng K; Eid N; Howard S; Jeong JH; Yi F; Guo J; Park CM; Bibian M; Wu W; Hernandez P; Park H; Wu Y; Luo JL; LoGrasso PV; Feng Y
J Med Chem; 2015 Feb; 58(4):1846-61. PubMed ID: 25621531
[TBL] [Abstract][Full Text] [Related]
7. Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo.
Luke RW; Ballard P; Buttar D; Campbell L; Curwen J; Emery SC; Griffen AM; Hassall L; Hayter BR; Jones CD; McCoull W; Mellor M; Swain ML; Tucker JA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6670-4. PubMed ID: 19854647
[TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors.
Oka Y; Yabuuchi T; Fujii Y; Ohtake H; Wakahara S; Matsumoto K; Endo M; Tamura Y; Sekiguchi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7534-8. PubMed ID: 23122859
[TBL] [Abstract][Full Text] [Related]
9. LIM kinases: cofilin and beyond.
Prunier C; Prudent R; Kapur R; Sadoul K; Lafanechère L
Oncotarget; 2017 Jun; 8(25):41749-41763. PubMed ID: 28445157
[TBL] [Abstract][Full Text] [Related]
10. Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors.
Sleebs BE; Nikolakopoulos G; Street IP; Falk H; Baell JB
Bioorg Med Chem Lett; 2011 Oct; 21(19):5992-4. PubMed ID: 21852129
[TBL] [Abstract][Full Text] [Related]
11. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials.
Manetti F
Eur J Med Chem; 2018 Jul; 155():445-458. PubMed ID: 29908439
[TBL] [Abstract][Full Text] [Related]
13. Lim kinases, regulators of actin dynamics.
Bernard O
Int J Biochem Cell Biol; 2007; 39(6):1071-6. PubMed ID: 17188549
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions.
Klemke M; Wabnitz GH; Funke F; Funk B; Kirchgessner H; Samstag Y
Immunity; 2008 Sep; 29(3):404-13. PubMed ID: 18771940
[TBL] [Abstract][Full Text] [Related]
15. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization.
Champiré A; Berabez R; Braka A; Cosson A; Corret J; Girardin C; Serrano A; Aci-Sèche S; Bonnet P; Josselin B; Brindeau P; Ruchaud S; Leguevel R; Chatterjee D; Mathea S; Knapp S; Brion R; Verrecchia F; Vallée B; Plé K; Bénédetti H; Routier S
Eur J Med Chem; 2024 May; 271():116391. PubMed ID: 38669909
[TBL] [Abstract][Full Text] [Related]
17. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization.
Yang N; Higuchi O; Ohashi K; Nagata K; Wada A; Kangawa K; Nishida E; Mizuno K
Nature; 1998 Jun; 393(6687):809-12. PubMed ID: 9655398
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological characterization of selective LIMK inhibitors.
Boland S; Bourin A; Alen J; Geraets J; Schroeders P; Castermans K; Kindt N; Boumans N; Panitti L; Vanormelingen J; Fransen S; Van de Velde S; Defert O
Bioorg Med Chem Lett; 2015 Sep; 25(18):4005-10. PubMed ID: 26233434
[TBL] [Abstract][Full Text] [Related]
19. T-cadherin modulates endothelial barrier function.
Andreeva AV; Han J; Kutuzov MA; Profirovic J; Tkachuk VA; Voyno-Yasenetskaya TA
J Cell Physiol; 2010 Apr; 223(1):94-102. PubMed ID: 20039275
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
Pandey D; Goyal P; Siess W
Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
